Back to search

Article

IL-2 stromal signatures dissect immunotherapy response groups in non-small cell lung cancer (NSCLC)

2021-08-07

Abstract excerpt

<h4>Introduction</h4> Immunotherapies, such as immune checkpoint inhibitors (ICI) have shown durable benefit in a subset of non-small cell lung cancer (NSCLC) patients. The mechanisms for this are not fully understood, however the composition and activation status of the cellular milieu contained within the tumour microenvironment (TME) is becomingly increasingly recognised as a driving factor in treatment-refract...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6fa50261-a3f2-5238-b08b-3c2a4c518362
DOI
10.1101/2021.08.05.21261528
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
IL-2 stromal signatures dissect immunotherapy response groups in non-small cell lung cancer (NSCLC)DOI 10.1101/2021.08.05.21261528
From Pixels to Insights: Unveiling Spatial Immune Associations of Immunotherapy Response in Non-Small Cell Lung Cancer using Multiplexed Tissue ImagingSemantic proximity
Spatial multiomics profiling reveals immune features in tumor-adjacent tissues associated with survival of stage I lung squamous cell carcinoma patientsSemantic proximity
Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 ExpressionSemantic proximity
An SPP1+ Macrophage / GZMK+ CD8 T-Cell Axis Mediates Immune Escape and Defines a Therapeutic Target in Non-Small Cell Lung CancerSemantic proximity
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structuresSemantic proximity
Single-Cell RNA Sequencing Reveals Tumor Microenvironment Remodeling after Neoadjuvant Immunotherapy in Non-small Cell Lung CancerSemantic proximity
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)Semantic proximity
Cancer cell-specific MHCII expression as a determinant of the immune infiltrate organization and function in the non-small cell lung cancer tumor microenvironmentSemantic proximity
Deciphering the tumour immune microenvironment cell by cellSemantic proximity
High-Plex and High-throughput Digital Spatial Profiling of non-small-cell lung cancer (NSCLC)Semantic proximity
Immunotherapeutic targets in non‐small cell lung cancerSemantic proximity
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancerSemantic proximity
Select a neighboring publication to make it the new centre.